Group 1 - The biovaccine sector experienced a decline of 0.30% as of the market close on November 28, ranking among the top losers in concept sectors [1] - Within the biovaccine sector, notable declines were observed in Hualan Biological, Jindike, and *ST Wanfang, while 24 stocks saw price increases, with Kanghua Biological, Shenzhou Cell, and Lanxiao Technology leading the gains at 2.10%, 1.66%, and 1.66% respectively [1][2] - The biovaccine sector faced a net outflow of 499 million yuan from major funds today, with 41 stocks experiencing net outflows, and 19 stocks seeing outflows exceeding 10 million yuan [2] Group 2 - The top three stocks with the highest net outflows in the biovaccine sector were Wantai Biological (-2.18%), *ST Wanfang (-4.11%), and Jindike (-6.55%), with net outflows of 68.27 million yuan, 41.63 million yuan, and 34.53 million yuan respectively [2][3] - Conversely, the stocks with the highest net inflows included Dezhan Health, New Source, and Meihua Biological, with net inflows of 12.45 million yuan, 5.47 million yuan, and 4.02 million yuan respectively [4]
生物疫苗概念下跌0.30%，主力资金净流出41股
Zheng Quan Shi Bao Wang·2025-11-28 10:08